Defending the Latest Class Actions: GLP-1 Injectables for Diabetes and Weight Loss

What is GLP-1? Scientists discovered the first glucagon-like peptide-1 agonists (“GLP-1”) in 1984.[1] The GLP-1 hormone helps the “pancreas … produce more insulin after meals.”[2] It also slows down the movement of food into the small intestine, which helps suppress appetite.[3] This combination of actions solidified GLP-1s eventual use for patients with diabetes. Over time, researchers and clinicians […]